- Clinical Interests
- Manic-depressive illness
- Treatment-resistant depression
- Medical Education
- MD, Albert Einstein College of Medicine
- Residency, Bellevue Hospital Center
- Fellowship, Yale-New Haven Hospital
- Board Certifications
- Boston: Massachusetts General Hospital
- Existing Patients
- Patient Gateway
- Insurances Accepted
- Aetna Health Inc.
- Beech Street
- Blue Cross Blue Shield - Blue Care 65
- Blue Cross Blue Shield - Indemnity
- Blue Cross Blue Shield - Managed Care
- Blue Cross Blue Shield - Partners Plus
- BMC HealthNet Mass Health MCO/ACO
- Cigna Behavioral Health
- Commonwealth Care Alliance
- Health Care Value Management (HCVM)
- Humana/Choice Care PPO
- Medicare - ACD
- OSW - Maine
- Private Health Care Systems (PHCS)
- Tufts Health Plan
- United Behavioral Health
- United Behavioral Health - MGH
Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.
- Patient Age Group
- Provider Gender
- Research Summary
Dr. Andrew Nierenberg has been at the Massachusetts General Hospital since 1992, where he holds his current positions. He is also Honorary Professor in the School of Medicine, Faculty of Health at Deakin University, Geelong Australia.
Dr. Nierenberg has published over 450 papers and has been listed in The Best Doctors in America for the treatment of mood and anxiety disorders in every edition since 1994. In 2000, he was awarded the Gerald L. Klerman Young Investigator Award and in 2014 the Gerald L. Klerman Senior Investigator Award by the Depression Bipolar Support Alliance. In 2013, Dr. Nierenberg was awarded the prestigious Brain and Behavior Research Foundation Colvin Prize for outstanding achievement in mood disorders research. In 2014, he was awarded the Mentorship Award for Exceptional Mentorship in the Research Arena at MGH. In 2014 and 2015, he was listed among the World’s Most Influential Scientific Minds by Thompson Reuters in recognition of ranking among the top 1% of researchers for most cited papers in psychiatry worldwide.
Dr. Nierenberg’s primary interests are bipolar depression and novel treatments. He lectures extensively, teaches, supervises, and mentors junior faculty, has an active clinical practice, consults to industry, and conducts clinical trials funded by federal, foundation, industry, and philanthropic sources. He serves as a peer reviewer for over 35 psychiatric journals. Dr. Nierenberg is a member of the editorial boards of over 15 journals and is the editor of Psychiatric Annals and is a deputy editor of Depression and Anxiety.
The Massachusetts General Hospital Bipolar Clinic and Research Program is launching a 10-site nationwide trial evaluating the real-world advantages and disadvantages of second generation mood stabilizing medications compared to lithium.
50 Staniford Street
Boston, MA 02114-2517